𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Applicability of lymphoscintigraphy with sentinel node biopsy to eccrine carcinoma of the head and neck

✍ Scribed by Amy S. Chang; Klaus Busam; Dennis H. Kraus


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
165 KB
Volume
25
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background.

Eccrine carcinoma of the head and neck has the propensity to metastasize both to regional and distant sites. When associated with nodal metastasis, there is a high incidence of distant spread of disease, ultimately being associated with the death of the patient. Management of the patient with clinically negative nodes remains controversial. Although elective nodal dissection has been performed, the impact of this intervention remains indeterminate. This case series serves as a feasibility study for use of the technique of lymphoscintigraphy with sentinel node biopsy for eccrine carcinoma arising in the head and neck.

Methods.

Two patients with eccrine carcinoma underwent sentinel node biopsy by way of the standard, three‐part technique using lymphoscintigraphy, 1% isosulfan blue dye, and intraoperative use of the gamma probe.

Results.

In each of these cases, the lymphoscintigram successfully identified sentinel lymph nodes. Intraoperative findings were significant for confirmation of sentinel nodes with the presence of blue dye in the lymph node. In one case, frozen section identified a positive sentinel lymph node, and the patient underwent definitive nodal dissection and postoperative radiotherapy. In the second case, immunohistochemistry as part of final pathology identified a single microscopic foci of metastatic eccrine carcinoma, for which the patient elected to receive definitive radiation therapy.

Conclusions.

This report documents the efficacy of lymphoscintigraphy with sentinel lymph node biopsy in identifying microscopic metastasis eccrine carcinoma in primary lesions arising in the head and neck. Β© 2003 Wiley Periodicals, Inc. Head and Neck 25: 879–882, 2003


πŸ“œ SIMILAR VOLUMES


Lymphatic drainage patterns of head and
✍ Doris Lin; Benjamin L. Franc; Mohammed Kashani-Sabet; Mark I. Singer πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 1 views

## Background: The purpose of this study was to evaluate lymphatic drainage patterns of head and neck cutaneous melanoma observed on preoperative lymphoscintigraphy and sentinel lymph node biopsy (slnb) and determine discordancy from clinically predicted lymphatic drainage patterns. ## Methods: W

The accuracy of head and neck carcinoma
✍ Taimur Shoaib; David S. Soutar; D. Gordon MacDonald; Ivan G. Camilleri; David J. πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## BACKGROUND. Sentinel lymph node (SLN) biopsy originally was described as a means of identifying lymph node metastases in malignant melanoma and breast carcinoma. The use of SLN biopsy in patients with oral and oropharyngeal squamous cell carcinoma and clinically N0 necks was investigated to det

A suggested method for sentinel node bio
✍ Taimur Shoaib; David S. Soutar; Joanne E. Prosser; David J. Dunaway; Henry W. Gr πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

Background. Debate continues over the management of the N0 neck in head and neck malignancy. Therefore, the possibility of performing sentinel node biopsy in these patients was investigated to formulate a method for the procedure. Methods. Patients undergoing prophylactic or therapeutic neck dissec

Sentinel node biopsy in patients with cu
✍ Fernando Gomez-Rivera; Alfredo Santillan; Andrea Barber McMurphey; George Parask πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 154 KB πŸ‘ 1 views

## Abstract ## Background. Controversy remains regarding the benefits of sentinel lymph node (SLN) biopsy for predicting survival in cutaneous melanoma of the head and neck (CMHN). ## Methods. We analyzed the factors associated with the recurrence and survival of CMHN patients treated in our ins